PriceTargets.com logo

DRI Healthcare Trust - DHT.UN Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: C$18.50
  • Forecasted Upside: 59.62%
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
C$11.59 As of 09/6/2024 01:00 AM ET
▲ +2.88 (33.07%)

This chart shows the closing price for DHT.UN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DRI Healthcare Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DHT.UN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DHT.UN

Analyst Price Target is C$18.50
▲ +59.62% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for DRI Healthcare Trust in the last 3 months. The average price target is C$18.50, with a high forecast of C$24.00 and a low forecast of C$14.00. The average price target represents a 59.62% upside from the last price of C$11.59.

This chart shows the closing price for DHT.UN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 7 investment analysts is to moderate buy stock in DRI Healthcare Trust. This rating has held steady since January 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/13/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/12/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/11/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/9/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/8/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/7/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/25/2024Truist FinancialLower TargetC$17.00 ➝ C$14.00
7/9/2024Stifel NicolausDowngradeBuy ➝ HoldC$22.00 ➝ C$15.00
7/9/2024CIBCLower TargetC$20.00 ➝ C$18.50
7/9/2024Royal Bank of CanadaLower TargetC$20.00 ➝ C$16.00
7/9/2024National BanksharesLower TargetOutperformC$23.50 ➝ C$17.50
7/9/2024Raymond JamesDowngradeStrong-Buy ➝ OutperformC$24.00
5/8/2024Canaccord Genuity GroupLower TargetBuyC$19.50 ➝ C$19.00
5/8/2024CIBCBoost TargetOutperformC$19.50 ➝ C$20.00
3/1/2024National BanksharesBoost TargetOutperformC$22.00 ➝ C$23.50
3/1/2024CIBCBoost TargetOutperformC$19.00 ➝ C$19.50
3/1/2024Raymond JamesUpgradeOutperform ➝ Strong-BuyC$22.00 ➝ C$24.00
3/1/2024Stifel NicolausBoost TargetBuyC$21.00 ➝ C$22.00
2/2/2024National BanksharesBoost TargetOutperformC$18.50 ➝ C$22.00
2/2/2024Raymond JamesBoost TargetOutperformC$21.00 ➝ C$22.00
2/2/2024CIBCBoost TargetOutperformC$18.00 ➝ C$19.00
2/2/2024ScotiabankBoost TargetOutperformC$22.00 ➝ C$24.00
2/2/2024Stifel NicolausBoost TargetBuyC$20.00 ➝ C$21.00
11/28/2023Royal Bank of CanadaReiterated RatingOutperform ➝ OutperformC$18.00
(Data available from 9/7/2019 forward)

News Sentiment Rating

0.72 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/10/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/11/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/10/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/9/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/9/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/8/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/7/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

DRI Healthcare Trust logo
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: C$11.59
Low: C$11.52
High: C$11.89

50 Day Range

MA: C$12.47
Low: C$11.17
High: C$16.08

52 Week Range

Now: C$11.59
Low: C$10.21
High: C$17.43

Volume

16,715 shs

Average Volume

44,023 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

3.94%

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of DRI Healthcare Trust?

The following Wall Street sell-side analysts have issued reports on DRI Healthcare Trust in the last year: Canaccord Genuity Group Inc., CIBC, National Bankshares, Inc., Raymond James, Royal Bank of Canada, Scotiabank, Stifel Nicolaus, and Truist Financial Co..
View the latest analyst ratings for DHT.UN.

What is the current price target for DRI Healthcare Trust?

8 Wall Street analysts have set twelve-month price targets for DRI Healthcare Trust in the last year. Their average twelve-month price target is C$18.50, suggesting a possible upside of 59.6%. Raymond James has the highest price target set, predicting DHT.UN will reach C$24.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of C$14.00 for DRI Healthcare Trust in the next year.
View the latest price targets for DHT.UN.

What is the current consensus analyst rating for DRI Healthcare Trust?

DRI Healthcare Trust currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for DHT.UN.

What other companies compete with DRI Healthcare Trust?

Other companies that are similar to DRI Healthcare Trust include Abattis Bioceuticals, Agraflora Organics International, Amplify Alternative Harvest ETF, Bio-Rad Laboratories and Blueberries Medical. Learn More about companies similar to DRI Healthcare Trust.

How do I contact DRI Healthcare Trust's investor relations team?

DRI Healthcare Trust's physical mailing address is 100 King Street West, Suite 7250 PO Box 62, Toronto, ON M5X 1B1, Canada. The company's listed phone number is 416-863-1865. The official website for DRI Healthcare Trust is www.dricapital.com. Learn More about contacing DRI Healthcare Trust investor relations.